Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
The Motley Fool
Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.
Continue Reading